This content is machine translated Lipid Management Guideline-compliant care up to date A fundamental factor in the field of cardiology is LDL cholesterol. Because without cholesterol, there is no atherosclerosis. Therefore, effective lipid management is paramount for the prevention of cardiovascular events.…
View Post 3 min This content is machine translated SGLT2 inhibitors Cardioprotective effect proven and found to be good – a statement One of the serious long-term consequences of diabetes mellitus is cardiovascular disease. Heart failure, in particular, is common in patients who have had diabetes for a long time. Recent study…
View Post 3 min This content is machine translated Angina pectoris Antianginal therapy shows no long-term benefit for prophylaxis Angina may persist or recur despite successful revascularization with percutaneous coronary intervention. In these cases, antianginal treatment is supplemented. To demonstrate the effectiveness of this approach, a clinical trial was…
View Post 12 min This content is machine translated Venous thromboembolism Risks associated with hormone therapy Venous thromboembolism (VTE) is the third most common cardiovascular disease in Central Europe. They manifest as deep vein thrombosis in about two-thirds of cases and with symptoms of pulmonary embolism… CME-Test
View Post 2 min This content is machine translated Anticoagulant therapy in COVID-19 patients. Antibodies to platelets promote thrombosis in COVID-19 infections. Early in the coronavirus pandemic, increased activation of blood clotting was noted in patients with COVID-19 infection. Coagulation studies at the University Hospital of Tübingen now show that platelets from…
View Post 2 min This content is machine translated Atrial fibrillation Mobile rhythm patch can detect atrial fibrillation at an early stage A mobile rhythm patch detects atrial fibrillation in high-risk patients ten times more frequently than conventional diagnostics. That is the finding of a new transatlantic study involving researchers from Canada…
View Post 4 min This content is machine translated Increased risk of dementia A weak heart is bad for the brain Heart problems result in impaired gene activity in the memory center of the brain, from which cognitive decline develops. Researchers at the German Center for Neurodegenerative Diseases (DZNE), the University…
View Post 2 min This content is machine translated Insights into the interaction Inflammation and fibrosis after myocardial infarction Under the leadership of Prof. Dr. Florian Leuschner, Managing Senior Physician at the Department of Cardiology, Angiology and Pneumology at Heideberg University Hospital (UKHD), an international research team has begun…
View Post 5 min This content is machine translated Diabetic nephropathy SGLT-2 inhibitor protects heart and kidney also in the real-world setting Type 2 diabetes mellitus (T2DM) significantly increases the risk of cardiovascular and renal diseases [1, 2]. However, SGLT-2 inhibitors not only lower blood glucose levels but also have cardio- and…
View Post 4 min This content is machine translated Coronary heart disease (CHD) What is the value of PCSK9 inhibitors for cholesterol lowering? The goal of lipid-lowering drug therapy is the prophylaxis of cardiovascular events. When statins and ezetimibe fail to achieve sufficient reductions in LDL cholesterol, or when one of these agents…
View Post 8 min This content is machine translated Psoriasis What is the role of the IL23/Th17 pathway in cardiovascular comorbidities? The IL23/Th17 axis plays an important role in the pathophysiology of psoriasis. A growing body of evidence suggests that inflammatory processes are involved in many cardiovascular and metabolic diseases associated…
